Distinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1A

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-13

  Chang, Jer Wei ^a   Hsu, Han Shui ^b   Ni, Huey Juin ^c   Chuang, Ching Ting ^c   Hsiung, Chi Hui ^a   Huang, Tim H ^d   Wang, Yi Ching ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN BLU; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CTCF; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; CCCTC-BINDING FACTOR; E2F1 PROTEIN, HUMAN; RASSF1 PROTEIN, HUMAN; REPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; ZMYND10 PROTEIN, HUMAN;

ARTICLE; BLU GENE; CANCER CELL CULTURE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME 3P; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; GEL MOBILITY SHIFT ASSAY; GENE CLUSTER; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULATOR ELEMENT; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN DOMAIN; RASSF1A GENE; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; CHROMOSOME 3; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; LUNG TUMOR; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 3; CPG ISLANDS; DNA METHYLATION; E2F1 TRANSCRIPTION FACTOR; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULATOR ELEMENTS; LUNG NEOPLASMS; PROTEIN BINDING; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 77958467213     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012847     Document Type: Article

References (43)

1. Fong KM, Sekido Y, Minna JD (1999) Molecular pathogenesis of lung cancer. J Thorac Cardiovasc Surg 118: 1136-1152.
2. Sekido Y, Fong KM, Minna JD (1998) Progress in understanding the molecular pathogenesis of human lung cancer. Biochim Biophys Acta 1378: F21-59.
3. Agathanggelou A, Dallol A, Zochbauer-Muller S, Morrissey C, Honorio S, et al. (2003) Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene 22: 1580-1588.
4. Thiagalingam S, Foy RL, Cheng KH, Lee HJ, Thiagalingam A, et al. (2002) Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Curr Opin Oncol 14: 65-72.
5. Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, et al. (1998) High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Cancer Res 58: 328-333.
6. Martinez A, Walker RA, Shaw JA, Dearing SJ, Maher ER, et al. (2001) Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features. Mol Pathol 54: 300-306.
7. Riquelme E, Tang M, Baez S, Diaz A, Pruyas M, et al. (2007) Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma. Cancer Lett 250: 100-106.
8. Tischoff I, Markwarth A, Witzigmann H, Uhlmann D, Hauss J, et al. (2005) Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int J Cancer 115: 684-689.
9. Tseng RC, Chang JW, Hsien FJ, Chang YH, Hsiao CF, et al. (2005) Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer. Int J Cancer 117: 241-247.
10. Donninger H, Vos MD, Clark GJ (2007) The RASSF1A tumor suppressor. J Cell Sci 120: 3163-3172.
11. Ortiz-Vega S, Khokhlatchev A, Nedwidek M, Zhang XF, Dammann R, et al. (2002) The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene 21: 1381-1390.
12. Rabizadeh S, Xavier RJ, Ishiguro K, Bernabeortiz J, Lopez-Ilasaca M, et al. (2004) The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death. J Biol Chem 279: 29247-29254.
13. Vos MD, Dallol A, Eckfeld K, Allen NP, Donninger H, et al. (2006) The RASSF1A tumor suppressor activates Bax via MOAP-1. J Biol Chem 281: 4557-4563.
14. Song MS, Song SJ, Ayad NG, Chang JS, Lee JH, et al. (2004) The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol 6: 129-137.
15. Liu L, Baier K, Dammann R, Pfeifer GP (2007) The tumor suppressor RASSF1A does not interact with Cdc20, an activator of the anaphase-promoting complex. Cell Cycle 6: 1663-1665.
16. Dallol A, Agathanggelou A, Tommasi S, Pfeifer GP, Maher ER, et al. (2005) Involvement of the RASSF1A tumor suppressor gene in controlling cell migration. Cancer Res 65: 7653-7659.
17. Vos MD, Martinez A, Elam C, Dallol A, Taylor BJ, et al. (2004) A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res 64: 4244-4250.
18. Hesson L, Bieche I, Krex D, Criniere E, Hoang-Xuan K, et al. (2004) Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Oncogene 23: 2408-2419.
19. Agathanggelou A, Cooper WN, Latif F (2005) Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 65: 3497-3508.
20. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, et al. (2001) Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93: 691-699.
21. Kim DH, Kim JS, Ji YI, Shim YM, Kim H, et al. (2003) Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Cancer Res 63: 3743-3746.
22. Yau WL, Lung HL, Zabarovsky ER, Lerman MI, Sham JS, et al. (2006) Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma. Int J Cancer 119: 2821-2826.
23. Hesson LB, Cooper WN, Latif F (2007) Evaluation of the 3p21.3 tumoursuppressor gene cluster. Oncogene 26: 7283-7301.
24. Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, et al. (2004) The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 23: 4793-4806.
25. Marsit CJ, Kim DH, Liu M, Hinds PW, Wiencke JK, et al. (2005) Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence. Int J Cancer 114: 219-223.
26. Gitan RS, Shi H, Chen CM, Yan PS, Huang TH (2002) Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res 12: 158-164.
27. Yan PS, Wei SH, Huang TH (2004) Methylation-specific oligonucleotide microarray. Methods Mol Biol 287: 251-260.
28. Yan PS, Shi H, Rahmatpanah F, Hsiau TH, Hsiau AH, et al. (2003) Differential sdistribution of DNA methylation within the RASSF1A CpG island in breast cancer. Cancer Res 63: 6178-6186.
29. Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, et al. (2002) PROMO: detection of known transcription regulatory elements using speciestailored searches. Bioinformatics 18: 333-334.
30. Strunnikova M, Schagdarsurengin U, Kehlen A, Garbe JC, Stampfer MR, et al. (2005) Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter. Mol Cell Biol 25: 3923-3933.
31. Bell AC, West AG, Felsenfeld G (2001) Insulators and boundaries: versatile regulatory elements in the eukaryotic. Science 291: 447-450.
32. Antes TJ, Namciu SJ, Fournier RE, Levy-Wilson B (2001) The 59 boundary of the human apolipoprotein B chromatin domain in intestinal cells. Biochemistry 40: 6731-6742.
33. Witcher M, Emerson BM (2009) Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. Mol Cell 34: 271-284.
34. Mund C, Beier V, Bewerunge P, Dahms M, Lyko F, et al. (2005) Array-based sanalysis of genomic DNA methylation patterns of the tumour suppressor gene p16INK4A promoter in colon carcinoma cell lines. Nucleic Acids Res 33: e73.
35. Zhang D, Bai Y, Ge Q, Qiao Y, Wang Y, et al. (2006) Microarray-based molecular margin methylation pattern analysis in colorectal carcinoma. Anal Biochem 355: 117-124.
36. Campanero MR, Armstrong MI, Flemington EK (2000) CpG methylation as a mechanism for the regulation of E2F activity. Proc Natl Acad Sci U S A 97: 6481-6486.
37. Zhang B, Chambers KJ, Leprince D, Faller DV, Wang S (2009) Requirement for chromatin-remodeling complex in novel tumor suppressor HIC1-mediated transcriptional repression and growth control. Oncogene 28: 651-661.
38. Gaszner M, Felsenfeld G (2006) Insulators: exploiting transcriptional and epigenetic mechanisms. Nat Rev Genet 7: 703-713.
39. Filippova GN (2008) Genetics and epigenetics of the multifunctional protein CTCF. Curr Top Dev Biol 80: 337-360.
40. Mukhopadhyay R, Yu W, Whitehead J, Xu J, Lezcano M, et al. (2004) The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide. Genome Res 14: 1594-1602.
41. Palakurthy RK, Wajapeyee N, Santra MK, Gazin C, Lin L, et al. (2009) Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression. Mol Cell 36: 219-230.
42. Muller J, Hart CM, Francis NJ, Vargas ML, Sengupta A, et al. (2002) Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell 111: 197-208.
43. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, et al. (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624-629.